Triple-negative breast cancer (TNBC) is an aggressive and clinically challenging subtype of breast cancer characterized by the absence of estrogen receptor, progesterone receptor, and HER2 expression. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.